Screener
Solid Biosciences Inc. SLDB Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | $(111,536) | $(78,762) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Amortization of discount on available-for-sale securities | (1,984) | (800) |
| Equity-based compensation expense | 10,768 | 6,486 |
| Depreciation and amortization expense | 786 | 793 |
| Non-cash lease expense | 1,257 | 1,162 |
| Change in fair value of derivative liabilities | 2,500 | 2,550 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments?
- Solid Biosciences Inc. (SLDB) reported accretion (amortization) of discounts and premiums, investments of $1.37M in Q2 2026.
- How has Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments increased by 179.7% year-over-year, from $488K to $1.37M.
- What is the long-term trend for Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 2 years (2023 to 2025), Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a -11.8% compound annual growth rate (CAGR), from $2.41M to $1.87M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to reconcile net income for the periodic amortization of premiums or accretion of discounts on investment securities. It reflects the gradual adjustment of the carrying value of debt securities toward their par value over time. Investors use this to isolate the impact of investment valuation changes from actual cash flows generated by operations.
Ask your AI about Solid Biosciences Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude